Literature DB >> 2784411

Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.

J G Shields1, R J Armitage, B N Jamieson, P C Beverley, R E Callard.   

Abstract

Surface IgM (sIgM) was increased up to 10 times on human tonsillar B cells activated with IL-4. No change was observed for surface IgD, IgG or IgE. Other activators of human B cells, such as TPA, EBV and anti-IgM resulted in increased expression of the low-affinity receptor for IgE (CD23), but had no effect on sIgM. IL-4 also increased sIgM expression on prolymphocytic leukaemic (PLL) B cells, whereas TPA significantly reduced the level of sIgM. The effect on sIgM thus seems specific for IL-4, and is consistent with the existence of a unique IL-4-dependent B-cell activation pathway. Preincubation with IL-4 did not 'prime' B cells to proliferate in response to subsequent exposure to anti-IgM, and slightly decreased the response to co-stimulation with IL-4 and anti-IgM. The increase in sIgM expression in response to IL-4, therefore, does not seem to be important for proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784411      PMCID: PMC1385091     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40).

Authors:  J Cairns; L Flores-Romo; M J Millsum; G R Guy; S Gillis; J A Ledbetter; J Gordon
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

3.  Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.

Authors:  J Gordon; M J Millsum; G R Guy; J A Ledbetter
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

5.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.

Authors:  R Noelle; P H Krammer; J Ohara; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications.

Authors:  A C Wang; E Tung; H H Fudenberg
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

7.  B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.

Authors:  R M Crawford; D S Finbloom; J Ohara; W E Paul; M S Meltzer
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

8.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

9.  Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.

Authors:  Y Hamaguchi; Y Kanakura; J Fujita; S Takeda; T Nakano; S Tarui; T Honjo; Y Kitamura
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

10.  B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.

Authors:  E M Rabin; J J Mond; J Ohara; W E Paul
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  7 in total

1.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  The antigen receptor complex on cord B lymphocytes.

Authors:  P J Macardle; H Weedon; M Fusco; S Nobbs; J Ridings; L Flego; D M Roberton; H Zola
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

3.  Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors.

Authors:  K Kicza; A Fischer; T Pfeil; J Bujanowski-Weber; W König
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Reduced expression of the interleukin-2-receptor gamma chain on cord blood lymphocytes: relationship to functional immaturity of the neonatal immune response.

Authors:  H Zola; M Fusco; H Weedon; P J Macardle; J Ridings; D M Roberton
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

5.  Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors.

Authors:  D Pandrau; S Saeland; V Duvert; I Durand; A M Manel; M T Zabot; N Philippe; J Banchereau
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-like.

Authors:  P D Katsikis; S B Cohen; J G Murison; J Uren; L M Hibbart; R E Callard; F Di Padova; M Feldmann; M Londei
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

7.  Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).

Authors:  S Lederman; M J Yellin; A Krichevsky; J Belko; J J Lee; L Chess
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.